Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry.

674 elderly and symptomatic patients undergoing initial percutaneous aortic balloon valvuloplasty enrolled in the NHLBI Balloon Valvuloplasty Registry (83% >70 years of age, 76% NYHA class III/IV CHF, 80% deemed inappropriate for aortic valve replacement).

Percutaneous balloon aortic valvuloplasty

Acute and 30-day follow-up results including hemodynamics, complications, mortality, and functional statushard clinical